In a novel study, the mRNA expression level of miR-27a, which activates the Wnt/β-catenin signaling pathway through the inhibition of FOXO1, was significantly higher in ovarian cancer tissues and in in vitro ovarian cancer cell lines (12). The gene discussed is FOXO1; the disease is ovarian carcinoma.